Page last updated: 2024-09-04

gw420867x and Headache

gw420867x has been researched along with Headache in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cass, LM; Dallow, NS; Jones, AE; Moore, KH; Prince, WT; Sisson, JR	1

Trials

1 trial(s) available for gw420867x and Headache

Article	Year
The bioavailability of the novel nonnucleoside reverse transcriptase inhibitor GW420867X is unaffected by food in healthy male volunteers. Journal of clinical pharmacology, 2001, Volume: 41, Issue:5 Topics: Adult; Area Under Curve; Biological Availability; Confidence Intervals; Cross-Over Studies; Dietary Fats; Food-Drug Interactions; Gastrointestinal Diseases; Half-Life; Headache; Humans; Least-Squares Analysis; Male; Metabolic Clearance Rate; Middle Aged; Quinoxalines; Reverse Transcriptase Inhibitors	2001

Article

Year

The bioavailability of the novel nonnucleoside reverse transcriptase inhibitor GW420867X is unaffected by food in healthy male volunteers.

Journal of clinical pharmacology, 2001, Volume: 41, Issue:5

Topics: Adult; Area Under Curve; Biological Availability; Confidence Intervals; Cross-Over Studies; Dietary Fats; Food-Drug Interactions; Gastrointestinal Diseases; Half-Life; Headache; Humans; Least-Squares Analysis; Male; Metabolic Clearance Rate; Middle Aged; Quinoxalines; Reverse Transcriptase Inhibitors

2001